• OPEN AN ACCOUNT
Indian Indices
Sensex
74,764.23 -813.35
( -1.08%)
Global Indices
Nasdaq
52,820.00 -615.25
(-1.15%)
Dow Jones
7,695.68 -43.92
(-0.57%)
Hang Seng
65,089.68 -179.65
(-0.28%)
Nikkei 225
10,664.98 -146.68
(-1.36%)
Forex
USD-INR
94.51 0.08
(0.08%)
EUR-INR
109.83 0.16
(0.15%)
GBP-INR
127.88 0.26
(0.20%)
JPY-INR
0.61 0.01
(0.93%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.3553764
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
34.1
111803.57
EPS(TTM)
Face Value()
Div & Yield %
40.59
2
0.94
 

As on: Sep 09, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,368.00 -15.95 46649 34.10
Stock Price Details
Open Price() 1,383.90
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,388.40
Today's Low () 1,368.00
52-Week High () 1672.2
152-Week Low () 1165.55
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.94
Eps 40.59
Book Value 423.3553764
Market Cap (.Cr) 111,803.57
Face Value 2
Market Lot 1
AGM Date Jun
Book Closure Date
ISIN No. INE059A01026


News
Invagen Pharmaceuticals enters licensing agreement with Qilu
Cipla inks exclusive partnership with Qilu Pharma for commercializing Pembrolizumab in US
Cipla inks exclusive licensing agreement with SBP Group for ADC Rolditamig Deuderuxtecan
Cipla and SBP Group sign exclusive license agreement for Rolditamig Deuderuxtecan
InvaGen receives EIR report for its facility in Hauppauge, New York
Cipla consolidated net profit declines 39.19% in the June 2026 quarter
Cipla drops after Q1 PAT tumbles 39% YoY to Rs 789 cr
Board of Cipla approves change in senior management
Cipla grants 24,709 stock options and ESARs
USFDA inspects Cipla subsidiary's manufacturing unit in New York
More
Corporate Details
Incoporation Year   : 1935
Chairman : Y K Hamied
Bussiness Group : Indian Private
Registered Office
Cipla Ltd
Cipla House Peninsula Buss Par,
Ganpatrao Kadam Mg Lower Parel,
Mumbai,
Maharashtra-400013
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-24826000
Fax:91-22-24826120
Fax:91-22-66317458
E-Mail : cosecretary@cipla.com, contactus@cipla.com
URL : http://www.cipla.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 100
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Shariah 50
  • NIFTY
  • CNX 500
  • CNX 100
  • CNX Pharma
  • CNX 200
  • NI15 Index
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi